127 related articles for article (PubMed ID: 30534824)
1. The prognostic value of CXCR4, α-SMA and WASL in upper lip basal cell carcinomas.
Sălan AI; Mărăşescu PC; Camen A; Ciucă EM; Matei M; Florescu AM; Pădureanu V; Mărgăritescu C
Rom J Morphol Embryol; 2018; 59(3):839-849. PubMed ID: 30534824
[TBL] [Abstract][Full Text] [Related]
2. Expression of CXCR4, MMP-13 and β-catenin in different histological subtypes of facial basal cell carcinoma.
Ciurea ME; Cernea D; Georgescu CC; Cotoi OS; Pătraşcu V; Pârvănescu H; Popa D; Pârvănescu V; Ciurea RN; Mercuţ R
Rom J Morphol Embryol; 2013; 54(4):939-51. PubMed ID: 24398989
[TBL] [Abstract][Full Text] [Related]
3. Expression of p53, D2-40 and α-smooth muscle actin in different histological subtypes of facial basal cell carcinoma.
Mercut R; Ciurea ME; Mărgăritescu C; Popescu SM; Crăitoiu MM; Cotoi OS; Voinescu DC
Rom J Morphol Embryol; 2014; 55(2):263-72. PubMed ID: 24969973
[TBL] [Abstract][Full Text] [Related]
4. Basal cell carcinoma of the skin with mixed histomorphology: a comparative study.
Bartoš V; Kullová M
Cesk Patol; 2016; 52(4):222-226. PubMed ID: 27869450
[TBL] [Abstract][Full Text] [Related]
5. A correlation of alpha-smooth muscle actin and invasion in micronodular basal cell carcinoma.
Christian MM; Moy RL; Wagner RF; Yen-Moore A
Dermatol Surg; 2001 May; 27(5):441-5. PubMed ID: 11359490
[TBL] [Abstract][Full Text] [Related]
6. Micronodular basal cell carcinoma: a distinct subtype? Relationship with nodular and infiltrative basal cell carcinomas.
Betti R; Menni S; Radaelli G; Bombonato C; Crosti C
J Dermatol; 2010 Jul; 37(7):611-6. PubMed ID: 20629826
[TBL] [Abstract][Full Text] [Related]
7. L-myc polymorphism in head and neck nonmelanoma skin and lower lip cancers.
Gözü A; Ergen A; Dayicioglu D; Yaylim I; Ozsoy Z; Isbir T
Arch Otolaryngol Head Neck Surg; 2008 Jul; 134(7):725-8. PubMed ID: 18645122
[TBL] [Abstract][Full Text] [Related]
8. Basal cell carcinoma on the vermilion border of the lip: a study of six cases.
de Sousa J; Sánchez Yus E; Rueda M; Rojo S
Dermatology; 2001; 203(2):131-4. PubMed ID: 11586011
[TBL] [Abstract][Full Text] [Related]
9. Site-specific inheritance of basal cell carcinoma.
Stoner PL; Barber MF
Cutis; 2012 Nov; 90(5):252-4. PubMed ID: 23270197
[TBL] [Abstract][Full Text] [Related]
10. Expression of CXCR4 is associated with progression and invasion in patients with nasal-surface basal cell carcinoma.
Xu CZ; Wang PH; Yan XJ; Wang T; Chen D; Zhang ZJ; Shi RJ
ORL J Otorhinolaryngol Relat Spec; 2013; 75(6):332-41. PubMed ID: 24401734
[TBL] [Abstract][Full Text] [Related]
11. Histopathological aspects of some rare forms of facial basal cell carcinoma.
MercuŢ R; Dast S; Ciurea ME; Mărgăritescu C; Popescu FD; Manolea HO; Scrieciu M; Ghelase ŞM
Rom J Morphol Embryol; 2017; 58(2):425-432. PubMed ID: 28730226
[TBL] [Abstract][Full Text] [Related]
12. Trisomy 6 in basal cell carcinomas correlates with metastatic potential: a dual color fluorescence in situ hybridization study on paraffin sections.
Nangia R; Sait SN; Block AW; Zhang PJ
Cancer; 2001 May; 91(10):1927-32. PubMed ID: 11346875
[TBL] [Abstract][Full Text] [Related]
13. Presence of ulceration, but not high risk zone location, correlates with unfavorable histopathological subtype in facial basal cell carcinoma.
Yalcin O; Sezer E; Kabukcuoglu F; Kilic AI; Sari AG; Cerman AA; Altunay IK
Int J Clin Exp Pathol; 2015; 8(11):15448-53. PubMed ID: 26823913
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of punch biopsy in subtyping basal cell carcinoma.
Kamyab-Hesari K; Seirafi H; Naraghi ZS; Shahshahani MM; Rahbar Z; Damavandi MR; Naraghi MM; Rezvani M; Aghazadeh N
J Eur Acad Dermatol Venereol; 2014 Feb; 28(2):250-3. PubMed ID: 22989368
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical Expression of Calponin in Cutaneous Basal Cell Carcinoma.
Bartoš V; Kullová M
Acta Dermatovenerol Croat; 2015; 23(4):254-9. PubMed ID: 26724876
[TBL] [Abstract][Full Text] [Related]
16. Clinical and histopathological characteristics of basal cell carcinoma in Chinese patients.
Chang JM; Gao XM
Chin Med J (Engl); 2013 Jan; 126(2):211-4. PubMed ID: 23324265
[TBL] [Abstract][Full Text] [Related]
17. Significant differences in nonmelanoma skin cancers of the upper and lower lip.
Dawn A; Lawrence N
Dermatol Surg; 2013 Aug; 39(8):1252-7. PubMed ID: 23725539
[TBL] [Abstract][Full Text] [Related]
18. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2.
Zagrodnik B; Kempf W; Seifert B; Müller B; Burg G; Urosevic M; Dummer R
Cancer; 2003 Dec; 98(12):2708-14. PubMed ID: 14669293
[TBL] [Abstract][Full Text] [Related]
19. Actin expression in purely nodular versus nodular-infiltrative basal cell carcinoma.
Law AM; Oliveri CV; Pacheco-Quinto X; Horenstein MG
J Cutan Pathol; 2003 Apr; 30(4):232-6. PubMed ID: 12680952
[TBL] [Abstract][Full Text] [Related]
20. Increased immunoreactivity of membrane type-1 matrix metalloproteinase (MT1-MMP) and β-catenin in high-risk basal cell carcinoma.
Oh ST; Kim HS; Yoo NJ; Lee WS; Cho BK; Reichrath J
Br J Dermatol; 2011 Dec; 165(6):1197-204. PubMed ID: 21729023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
